Blank Bio
RNA intelligence for precision medicine
Blank Bio is active in the healthcare space based in San Francisco, CA, USA.
Profile
Blank Bio is an applied AI research lab focused on increasing the success rates of clinical trials. We do this by training RNA foundation models that learn the patterns that shape disease progression and patient response to treatment. We aim to help pharma make more informed decisions in clinical trials by capturing the biology that makes each patient’s tumour unique.
We’re a technical team of AI scientists and engineers from companies including Recursion, Deep Genomics, DeepMind, and Amazon, and institutions including Memorial Sloan Kettering Cancer Centre, Stanford, and the Vector Institute.
The company sits in the healthcare segment, where it competes on its core product or service.
San Francisco, CA, USA is where the company is located.
The company is listed at the Summer 2025 stage of development.
Recorded headcount: 6 employees.
Directory analysis
Blank Bio is a San Francisco-based AI research lab that develops RNA foundation models to improve clinical trial success rates. By modeling disease progression and patient response, it helps pharma capture tumor biology for better trial decisions.
Positioning: The company targets the precision medicine and clinical trial optimization market, leveraging advanced AI and RNA data to provide insights for pharma. Its small technical team and focus on AI-driven biology place it among niche biotech AI startups.
Note: Blank Bio focuses on RNA-based AI to aid pharma in clinical trial design.
Auto-generated directory analysis from public data · updated 10 Oct 2026. Informational only, not investment advice.
| Sector | Healthcare |
|---|---|
| Headquarters | San Francisco, CA, USA |
| Country | USA |
| Employees | 6 |
| Stage | Summer 2025 |
Website: blank.bio
Browse related
Create a free account